Extracellularly, CA-125 is the best-known biomarker for ovarian cancer [28], and it has been observed to be up-regulated in multiple malignancies as well as strongly associated with poor prognosis [29,30,31]. The gene discussed is MUC16; the disease is ovarian carcinoma.